Metabolic Syndrome Insulin Infusion Holdings LLC
treatment of metabolic disorders, including diabetes.
Based in VA
🤖
AI Overview
With $105K in lobbying spend across 8 quarterly filings, Metabolic Syndrome Insulin Infusion Holdings LLC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.
$105K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $45K |
| 2025 | $60K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Accounting
- •education around the company's healthcare value proposition
- •education around MSII's value proposition to treat metabolic health disorders.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.